NYSE ARCA | ETF
The fund, under normal circumstances, invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective.
The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards (GICS).
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 1.72% |
| RVMD | Revolution Medicines Inc | Healthcare | Biotechnology | 1.63% |
| RNA | Avidity Biosciences Inc | Healthcare | Biotechnology | 1.43% |
| KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 1.41% |
| BBIO | BridgeBio Pharma Inc | Healthcare | Biotechnology | 1.30% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 1.29% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 1.26% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 1.25% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 1.24% |
| MDGL | Madrigal Pharmaceuticals Inc | Healthcare | Biotechnology | 1.23% |
| PRAX | Praxis Precision Medicines Inc | Healthcare | Biotechnology | 1.16% |
| ROIV | Roivant Sciences Ltd | Healthcare | Biotechnology | 1.15% |
| IONS | Ionis Pharmaceuticals Inc | Healthcare | Biotechnology | 1.15% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 1.14% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 1.13% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 1.12% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 1.06% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 1.06% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 1.03% |
| EXEL | Exelixis Inc | Healthcare | Biotechnology | 1.02% |